Jupiter Neurosciences, Inc. (JUNS) News
Track canonical SquawkNews coverage tagged to JUNS, Jupiter Neurosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Jupiter Neurosciences Tumbles on Nasdaq Delisting Notice
Jupiter Neurosciences Tumbles on Nasdaq Delisting Notice
EQUITY | Aug 28, 2026, 10:00 PM UTC
L
Jupiter Neurosciences receives notice of delisting
Jupiter Neurosciences has received a notice of delisting.
EQUITY | Aug 28, 2026, 08:15 PM UTC
H
Jupiter Neurosciences Announces Reverse Stock Split
Jupiter Neurosciences does reverse stock split
EQUITY | Aug 05, 2026, 12:01 PM UTC
L
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
In this week's "Psychedelic," recurring series focused on psychedelic stock news, looks back on a license agreement, enrollment completion and a patent filing. PHARMALA, JUPITER ENTER LICENSE AGREEMENT: PharmAla Biotech
EQUITY | Jul 23, 2026, 03:07 PM UTC
H
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket
Shares of Universe Pharmaceuticals Inc (NASDAQ: UPC ) rose sharply in pre-market trading after the company announced it will acquire Best Praise International for $10.75 million. Universe Pharmaceuticals shares jumped 22
RATES | Jun 29, 2026, 11:03 AM UTC
M
12 Health Care Stocks Move
Gainers Universe Pharmaceuticals (NASDAQ: UPC ) stock moved upwards by 168.2% to $7.94 during Friday's after-market session. The market value of their outstanding shares is at $1.8 million. Tvardi Therapeutics (NASDAQ: T
EQUITY | Jun 26, 2026, 11:20 PM UTC